Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Antibacterial play Entasis raises $50M series B

    Entasis Therapeutics Inc. (Waltham, Mass.) raised $50 million in a series B round led by new investor Clarus Ventures. Frazier Healthcare Partners, Novo A/S (Hellerup, Denmark) and Eventide Funds also participated. …

    Published on 4/4/2016
  • FINANCIAL NEWS: Human Longevity raises $220M series B

    Human Longevity Inc. (San Diego, Calif.) raised $220 million in a series B financing that included Illumina Inc. (NASDAQ:ILMN), Celgene Corp. (NASDAQ:CELG) and GE Ventures. Human Longevity said its series A investors …

    Published on 4/4/2016
  • FINANCIAL NEWS: Metabomed caps $18M series A

    Cancer play Metabomed Ltd. (Yavne, Israel) said it raised an undisclosed amount in an extension of its series A round, bringing the round's total to $18 million. New investors Pfizer Inc. (NYSE:PFE) and Arkin Holdings …

    Published on 4/4/2016
  • FINANCIAL NEWS: Anacor raises $250M in note deal

    Anacor Pharmaceuticals Inc. (NASDAQ:ANAC) raised $250 million in a private placement of senior convertible notes. The unsecured notes bear 2% interest, mature in 2023 and initially convert at $70.82, which is a 21% …

    Published on 4/1/2016
  • FINANCIAL NEWS: Burrill settles with SEC, accepts permanent ban

    G. Steven Burrill and two other members of Burrill Capital Management's team agreed to be barred permanently from the securities industry to settle an SEC investigation into Burrill's alleged embezzlement from the 2006-…

    Published on 3/31/2016
  • FINANCIAL NEWS: Antibiotic play Zavante raises $45M

    Zavante Therapeutics Inc. (San Diego, Calif.) raised $45 million in a series A round co-led by Frazier Healthcare Partners and Longitude Capital. Aisling Capital also participated. The round comprised $35 million in new…

    Published on 3/30/2016
  • FINANCIAL NEWS: Gadeta raises EUR 7M for T cell therapies

    Gadeta B.V. (Utrecht, the Netherlands) raised EUR 7 million ($7.8 million) in a series A round led by Baxalta Ventures and Medicxi Ventures. Gadeta's founders, management and Utrecht Holdings also participated. Gadeta …

    Published on 3/29/2016
  • FINANCIAL NEWS: Organ-on-chip play Emulate raises $28M

    Emulate Inc. (Boston, Mass.) raised $28 million in a series B round. The company plans to expand its Organ-Chip portfolio and commercialize its Human Emulation System.New investors included OS Fund, Atel Ventures, and …

    Published on 3/28/2016
  • FINANCIAL NEWS: Quaker's Gavin passes away

    Brenda Gavin, a founding partner at Quaker Partners, passed away March 17. She co-founded the firm in 2002 with Sherrill Neff. Previously, she was president of the S.R. One venture arm of GlaxoSmithKline plc (LSE:GSK; …

    Published on 3/28/2016
  • FINANCIAL NEWS: Anti-infective play Iterum debuts with $40M

    Iterum Therapeutics Ltd. (Dublin, Ireland) raised $40 million in a series A round led by Frazier Healthcare Partners. Canaan Partners, Sofinnova Ventures and New Leaf Venture Partners also participated. The newco also …

    Published on 3/24/2016
  • FINANCIAL NEWS: Frazier closes $525M growth buyout fund

    Frazier Healthcare Partners closed its Frazier Healthcare Growth Buyout Fund VIII at $525 million. It is the firm's first fund dedicated to growth buyouts of profitable healthcare companies.Frazier said the fund …

    Published on 3/24/2016
  • FINANCIAL NEWS: Paul Allen to invest $100M in biotech

    Philanthropist Paul Allen said he will invest $100 million in bioscience over 10 years via the Paul G. Allen Frontiers Group, a new investment vehicle. The group committed $10 million over four years to each of two …

    Published on 3/24/2016
  • FINANCIAL NEWS: SillaJen raises $37M in venture round

    SillaJen Inc. (Busan, South Korea) raised $37 million in a venture round, including $12 million from Medivate Partners. SillaJen VP of Product and Alliance Management Robin Scully told BioCentury that Hana Financial …

    Published on 3/24/2016
  • FINANCIAL NEWS: Vitae raises $35M in follow-on

    Vitae Pharmaceuticals Inc. (NASDAQ:VTAE) raised $35 million through the sale of 5.8 million shares at $6 in a follow-on underwritten by Piper Jaffray, BMO Capital Markets and Wedbush PacGrow. It proposed the offering …

    Published on 3/24/2016
  • FINANCIAL NEWS: Celator raises $38M in follow-on

    Celator Pharmaceuticals Inc. (NASDAQ:CPXX) raised $38 million through the sale of 4 million shares at $9.50 in a follow-on underwritten by Stifel, Needham, Roth Capital Partners, H.C. Wainwright and National Securities.…

    Published on 3/23/2016
  • FINANCIAL NEWS: Corvus slips in first trading day

    Immuno-oncology company Corvus Pharmaceuticals Inc. (NASDAQ:CRVS) lost $0.75 to $14.25 in its first day of trading Wednesday after it raised $70.5 million in an IPO. The company priced at the bottom of its $15-$17 range…

    Published on 3/23/2016
  • FINANCIAL NEWS: Diagnostics play Clinical Genomics raises $15M

    Clinical Genomics Pty. Ltd. (North Ryde, Australia) closed a $15 million series A round led by Australian venture firm OneVentures.This year, Clinical Genomics plans to launch its Gemini test in the U.S. for post-…

    Published on 3/23/2016
  • FINANCIAL NEWS: Quanterix raises $46M in D round

    Diagnostic play Quanterix Corp. (Lexington, Mass.) raised $46 million in a series D round led by new investors Arch Overage Fund, Cormorant Asset Management and Trinitas Capital.Existing investors Arch Venture Partners,…

    Published on 3/23/2016
  • FINANCIAL NEWS: Science Exchange raises $25M in series B

    Science Exchange Inc. (Palo Alto, Calif.) raised $25 million in a series B round led by Maverick Capital Ventures. Union Square Ventures, Index Ventures, OATV, Collaborative Fund, YC Continuity Fund, and individuals …

    Published on 3/23/2016
  • FINANCIAL NEWS: Corvus raises $70.5 million in IPO

    Immuno-oncology company Corvus Pharmaceuticals Inc. (NASDAQ:CRVS) raised $70.5 million through the sale of 4.7 million shares at $15 in an IPO underwritten by Credit Suisse, Cowen, Guggenheim and Cantor Fitzgerald. …

    Published on 3/22/2016
  • FINANCIAL NEWS: Syntimmune raises second series A tranche

    Syntimmune Inc. (New York, N.Y.) raised $10 million in the second tranche of a planned $26 million series A round co-led by Apple Tree Partners and the Baxalta Ventures arm of Baxalta Inc. (NYSE:BXLT). Partners …

    Published on 3/22/2016
  • FINANCIAL NEWS: Topas spins out of Evotec, raises series A

    Evotec AG (Xetra:EVT) spun out Topas Therapeutics GmbH (Hamburg, Germany), which plans to develop nanoparticle-based therapeutics that will induce antigen-specific immune tolerance in the liver to treat autoimmune and …

    Published on 3/22/2016
  • FINANCIAL NEWS: Atlantic raises $24M venture round

    Atlantic Healthcare plc (Cambridge, U.K.) raised $24 million in a venture round from Lorin Johnson and other founders of Salix Pharmaceuticals Inc., Fullbrook Thorpe Investments, LDC and undisclosed existing investors.…

    Published on 3/21/2016
  • FINANCIAL NEWS: Arch raising $400M fund

    Arch Venture Partners is raising Arch Venture Fund IX, a planned $400 million fund, according to an SEC filing. The firm's eighth fund closed at $410 million in August 2014 (see BioCentury, Sept. 1, 2014).

    Published on 3/18/2016
  • FINANCIAL NEWS: Norway's BerGenBio closes venture round

    BerGenBio A/S (Bergen, Norway) raised NOK212 million ($25.1 million) in a venture round from existing investors, including Investinor A/S and Meteva A/S.BerGenBio's BGB324 is in Phase Ib testing to treat non-small cell …

    Published on 3/18/2016

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993